Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use
Antibiotic resistance in patients with cirrhosis continues to draw significant attention. With a propensity to frequent hospitalisations, patients with cirrhosis are subject to frequent antibiotic prescription. This increases their risk of developing resistance to one or more antimicrobial agents,...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2021-09-01
|
| Series: | European Medical Journal |
| Online Access: | https://www.emjreviews.com/hepatology/article/review-of-rifaximin-a-summary-of-the-current-evidence-and-benefits-beyond-licensed-use-j190321/ |